Surveillance of Respiratory Pathogens and Brand-Specific Vaccine Effectiveness in Adults Hospitalised with SARI: An Observational Study (former id.DRIVE surveillance study of respiratory pathogens in adults hospitalised for severe acute respiratory infection (SARI) across Europe)

28/02/2024
28/09/2026
EU PAS number:
EUPAS1000000012
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Surveillance study_Protocol_V1.0_21 Mar 2024.pdf

English (832.64 KB - PDF) View document
Updated protocol

Master Protocol Surveillance + VE_V3.0_02 Mar 2026.pdf

First published: 14/09/2026
English (830.1 KB - PDF) View document

Master Protocol Surveillance + VE_V3.0_02 Mar 2026.pdf

First published: 14/09/2026
English (830.1 KB - PDF) View document

Surveillance Study protocol V2.0_23 Apr 2025.pdf

First published: 23/04/2026
English (818.46 KB - PDF) View document

RSV Vaccine Effectiveness protocol v3.0_21 Feb 2025.pdf

First published: 23/04/2026
English (856.05 KB - PDF) View document

Surveillance Study protocol V2.0_23 Apr 2025.pdf

First published: 16/09/2025
English (818.46 KB - PDF) View document
Study results
Study report
Other information
Publications
Study publications
id.DRIVE publications list